High flow demand on small arterial coronary bypass conduits promotes graft spasm  by Spence, Paul A. et al.
HIGH FLOW DEMAND ON 
SMALL ARTERIAL 
CORONARY BYPASS 
CONDUITS PROMOTES 
GRAFT SPASM 
Despite the superior long-term patency of arterial grafts, surgeons are often 
reluctant to use arterial grafts on coronary vessels that supply large areas 
of myocardium because postoperative shock may occur. We hypothesized 
that supramaximal flow through small arterial conduits would decrease 
distal intraluminal pressure, thereby reducing afterload on the smooth 
muscle and rendering the arterial graft vulnerable to spasm. Fourteen 
internal thoracic and eight gastroepiploic arteries were harvested from 
adult pigs (220 to 250 pounds). Arteries were mounted on a computer- 
controlled perfnsion system with inflow pressure at 80 mm Hg and outflow 
resistance adjusted to simulate normal (in situ) or supramaximal (coro- 
nary artery bypass graft) flow demands. Artery pressures and flow rates 
were measured at baseline and after norepinephrine was added to the 
system. Internal thoracic arteries had no hemodynamic response to nor- 
epinephrine at normal flow. Under supramaximal flow demands, large 
internal thoracic arteries (2.5 to 3.0 mm) had no hemodynamic response to 
norepinephrine. However, for small internal thoracic arteries (2.1 to 2.9 
mm), norepinephrine r duced distal internal thoracic arterial pressure 
(63.2 - 2.2 to 27.0 - 1.9 mm Hg) and flow rate (99.4 _+ 5.0 to 45.4 _+ 2.7 
ml/min, median effective dose = 9.12 x 10 -9 mol/L). Under normal flow 
demands, the flow rate in gastroepiploic arteries (1.0 to 2.0 mm diameter) 
decreased (14.1 - 0.5 to 4.8 - 0.8 ml/min, p < 0.05) only at high 
concentrations of norepinephrine (median effective dose = 1.26 x 10 -6 
mol/L). Supramaximal flow demands reduced istal gastroepiploic arterial 
pressure (77.5 -+ 0.5 to 49.5 --- 3.8 mm Hg, p < 0.05), which resulted in a 
greater decrease in flow rate (80.0 - 3.7 to 6.8 - 1.6 ml/min, p < 0.05) at 
lower concentrations of norepinephrine, (median effective dose = 3.24 x 
10 -s mol/L,p < 0.05). In four studies in internal thoracic arteries and eight 
in gastroepiploic arteries, arteries were cut in half, reattached, and 
reperfused. The proximal half of the internal thoracic artery did not 
respond to norepinephrine, but the distal half had a 53% _ 7% decrease in 
flow. Both gastroepipioic artery halves reacted and flow rate decreased by 
88% - 2% (proximal half) and 89% - 3% (distal half). In conclusion, small 
arterial conduits develop large transconduit pressure gradients under 
supramaximal flow demands. Under these conditions, arteries are very 
sensitive to vasoconstrictors and flow may cease with higher drug concen- 
trations. Myocardial failure after arterial bypass grafting to coronary 
vessels supplying large amounts of myocardium may result from an 
increased sensitivity to vasoconstriction leading to graft spasm and myo- 
cardial ischemia. (J THORAC CARDIOVASC SURG 1995;110:952-62) 
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S ince the unequivocal demonstration i  the inter- nal thoracic artery (ITA) of improved graft 
patency, patient survival, and fewer late postopera- 
tive cardiac complications, the ITA has become the 
conduit of choice for coronary artery bypass graft- 
ing. 1-3 Almost all ITA grafts are patent at 10 years, 
whereas two thirds of saphenous vein grafts are 
occluded or diseased at 10 years. 3-5 It is not surpris- 
ing that numerous attempts have been made to 
expand the use of arterial grafts. Some surgeons 
perform bilateral ITA grafting, and others use gas- 
troepiploic artery (GEA), inferior epigastric artery, 
or radial artery grafts. 6
Although the arterial grafts are disease resistant, 7 
initially the ITA graft delivers less flow to the 
coronary arteries in comparison with that delivered 
by saphenous vein grafts, 8and this lower flow can be 
further reduced by spastic reactions of the ITA. 9 
Insufficient graft flow can result in early and late 
myocardial ischemia, s'lo ITA grafts may be partic- 
ularly vulnerable if the initial native flow require- 
ment is high. Such conditions may exist when the 
ITA is grafted to a coronary bed with a large distal 
runoff, as may occur with sequential grafting, n or 
when the ITA graft serves a perfusion bed with a 
physiologically increased resting flow requirement, 
as may occur with ventricular hypertrophy. 1z-t4 One 
particularly lethal situation appears to result from 
the replacement of a diseased, but patent vein graft 
to the left anterior descending coronary artery with 
an ITA alone. 15 
This study examined why an artery that normally 
does not exhibit spasm becomes vulnerable to spasm 
when used as a bypass graft. We hypothesized that 
supramaximal f ow demands would decrease the 
distal pressure within the conduit (afterload) and 
thus increase the sensitivity to constrictors. To elim- 
inate neural and humoral effects, we used an in vitro 
perfused artery preparation. In both porcine ITAs 
and GEAs, the response to norepinephrine was 
measured under normal and supramaximal f ow 
rates. 
Methods 
The pigs and porcine tissue used in this study were 
handled in the laboratory according to the guidelines et 
by the American Physiological Society. The University of 
Louisville Animal Care and Use committee approved this 
protocol. 
Experimental preparation. At the slaughterhouse, por- 
cine stomachs or sternums, or both, were harvested from 
adult pigs (200 to 250 pounds), placed in cold physiologic 
salt solution (approximately 5 ° C), and transported toour 
laboratory within 10 minutes. At the laboratory the ITA 
(n = 14) or GEA (n = 8) artery segments (10 to 12 cm 
long) were excised from the specimens with an electro- 
cautery knife and with the arterial branches occluded with 
the use of small hemoclips. The arteries were then can- 
nulated with a trimmed 14-gauge Angiocath catheter 
(Deseret Medical, Sandy, Utah) and attached to a perfu- 
sion system. 16-18 
The perfusion system (Fig. 1) consisted of a flow pump 
(Masterflex model 7013, Cole-Palmer International, Chi- 
cago, I11.), a reservoir, an arterial bath, and two distal 
resistances. The reservoir (100 ml) and arterial bath 
contained a physiologic salt solution composed of (in 
millimoles per liter): NaC1 130.0, KC1 4.7, CaClz 1.6, 
KH2PO 4 1.2, MgSO 4 0.7, NaSO 4 2.4, NaHCO 3 14.9, 
dextrose 5.5, and ethylenediaminetetraacetic acid (10 -7 
mol/L), pH 7.4. All solutions were maintained at 37°C 
and were equilibrated with 95% 0 2 and 5% CO2. 
Pressures proximal and distal to the arterial segment 
were measured. The pressure transducers (Spectramed 
Inc., Critical Care Division, Oxnard, Calif.) were carefully 
calibrated to ensure equal sensitivity by simultaneously 
exposing the pressure transducers to the same pressure. 
The computer maintained a constant perfusion pressure. 
The output signal from the feedback control circuit (Fig. 
1) was used to provide perfusion flow rates and was 
calibrated by timed collections using a graduated cylinder. 
All data were recorded on a physiologic recorder (model 
1000, CWE Inc., Ardmore, Pa.). The proximal and distal 
pressure signals were processed with an analog-to-digital 
converter (model STA-AP board, Metra-Byte, Taunton, 
Mass.) and supplied to an Apple II+ microcomputer 
(Apple Computer Company, Cupertino, Calif.). In all 
experiments, a constant perfusion pressure (80 mm Hg) 
was applied to the arterial segment and the artery was 
allowed to stabilize for 2 hours. The arterial ength and 
perfusion pressure were kept constant throughout subse- 
quent interventions. 
Experimental protocol. The ITA and GEA were per- 
fused at 80 mm Hg and high distal resistance. This gave a 
flow rate of about 15 to 20 ml/min. This design simulated 
normal perfusion pressure and flow rates for 1.5 to 2 mm 
diameter arteriesW; that is, the normal flow demanc~s for 
arteries of this diameter. Norepinephrine was then incre- 
mentally added to the perfusate to obtain molar concen- 
trations ranging from 10 -9, 3.3 × 10 9, 10-8... to 10 5. 
Each norepinephrine concentration was maintained for at 
least 3 minutes or until a steady-state response was 
obtained. Hemodynamic variables were recorded contin- 
uously, digitized (every second), and stored in the Apple 
II+ microcomputer. 
The perfusate was then replaced with fresh physiologic 
salt solution and the artery was allowed to stabilize for 2 
hours. The distal resistance was set to allow a maximal 
flow rate of 100 to 120 ml/min. This design simulated 
maximal coronary flow demands: flow conditions in the 
graft that are often present after bypass operations. The 
norepinephrine dose-response relation was determined as 
previously described herein. In half the experiments, this 
order was reversed: that is, low distal resistance and 
supramaximal flow were used on first exposure to norepi- 
9 5 4 Spence, Montgomery, Santamore 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
[P rox ima l  Pressure &9~ % 02 CO2 
Transducer 
I PSS o e 
< ~  Flow 
Computer 
~mp 
t 
Distal Resistance 
al Pressure 
'ransducer 
Flow 
$ 
PSS 
oo  I 
Perfusate 
95%O2 & 5%CO2 
Fig. 1. Diagram of perfusion apparatus. Physiologic salt solution (PSS) was pumped through arterial 
segment at constant proximal pressure by computer feedback control. 
nephrine and high distal resistance and normal flow on 
second exposure to norepinephrine. 
If the artery had no measurable flow decrease in 
response to norepinephrine, the artery was fixed as 
described later. For arteries in which norepinephrine 
reduced flow, the arteries were then cut in half. Both 
the proximal and distal segments were reattached to the 
perfusion systems and pressures and flow rates were 
measured separately in each segment. The perfusate 
was replaced with fresh physiologic salt solution and the 
arterial segments were allowed to stabilize for 2 hours 
at 80 mm Hg. With the perfusion pressure at 80 mm Hg 
and a low distal resistance, the norepinephrine dose- 
response relation was determined for each segment. 
The perfusate was replaced with fresh physiologic salt 
solution and the arteries flushed and flow rates re- 
turned to baseline levels. All arteries, including those 
without a measurable flow response to norepinephrine, 
were then fixed by perfusion with a 10% formalin 
solution at 80 mm Hg. At 1 cm increments along its 
length, the artery was cut into 2 mm rings. A slide of 
arterial rings was then obtained with a 35 mm camera 
(K1000, Pentax, Garden City, N.Y.) equipped with a 
macro lens. The lens provided optical magnification 
with high resolution. To enhance contrast, a black sheet 
was placed under the optically clear bath. Thus the 
artery appeared white against a black background. For 
calibration purposes, a metric ruler was placed by the 
artery. Slides were obtained on Kodak film (Ekta- 
chrome 100, Kodak, Rochester, N.Y.). 
Data analysis. The artery resistance was calculated as 
(proximal pressure minus distal pressure) divided by 
flow. The mean and standard errors were calculated for 
the initial and final values for flow rate, pressure, and 
distal resistance. For each norepinephrine dose re- 
sponse, the half maximal effective concentration (EDs0) 
was determined by a log-logit transformation of the 
dose-response r lationship for each experiment by solv- 
ing for the 50% dose level. The pressures, flow rates, 
and resistance values were compared with a Student's t 
test with a Bonferroni correction for multiple compar- 
ison where appropriate. 
Dimensional analysis was conducted by projecting 
the image of the artery. For each arterial ring we 
measured two perpendicular diameters. Three to four 
rings were analyzed for the proximal, middle, and distal 
areas of the artery. These diameters were then aver- 
aged. For these average values, the means and standard 
errors were calculated for the proximal, middle, and 
distal segments. Findings in the diameter segments 
were compared by Student's t test with a Bonferroni 
correction for multiple comparison. 
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Fig. 2. A and B, Typical effects of norepinephrine (NE) 
on distal pressure and flow rate in one GEA. GEA was 
perfused with high distal resistance, that is, normal flow 
demands. At arrows, norepinephrine was added incremen- 
tally to perfusate. At higher concentrations, orepineph- 
rine decreased istal pressure and flow rate. For same 
artery, B shows response with low distal resistance, that is, 
supramaximal flow demands. Now at lower norepineph- 
rine concentration, distal pressure and flow rate started to 
decrease. 
Results 
Hemodynamics.  All GEAs responded to norepi- 
nephrine. Fig. 2, A, plots proximal pressure, distal 
pressure, and flow versus time from one GEA 
experiment. In this example, the GEA was perfused 
at 80 mm Hg with a high distal resistance, that is, 
normal flow demands. The initial drop in distal 
pressure was only 4 mm Hg with a flow rate of 15 
ml/min. At the arrows, norepinephrine was added 
incrementally to the perfusate. The distal pressure 
and flow began to decrease at a norepinephrine 
concentration of 3.3 × 10 -7 mol/L. Distal pressure 
Fig. 3. A and B, Typical pressure and flow data at supra- 
maximal flow demands for two ITAs. Larger ITA was 
hemodynamically nonresponsive to norepinephrine (NE); 
even at 10 -5 mol/L norepinephrine distal pressure and 
flow rate were unaltered (A). For smaller ITA, response to 
norepinephrine is similar to that of GEA. Increasing flow 
demands changed effective sensitivity to norepinephrine: 
with supramaximal flow demands (B), distal pressure and 
flow rate started to decrease at norepinephrine concen- 
tration of 10 -9  mÙ•/L. 
and flow decreased further as the norepinephrine 
concentration i creased to a final distal pressure of 
33 mm Hg and flow rate of 6 ml/min (EDso = 8.0 × 
10-7). 
For same artery, Fig. 2, B, shows the response at 
80 mm Hg with a low distal resistance, that is, 
supramaximal flow demands. Compared with results 
shown in Fig. 2, A, the initial distal pressure was 
lower (61 mm Hg versus 77 mm Hg) because of the 
viscous pressure losses caused by the higher flow 
rates. Again, norepinephrine was added incremen- 
tally to the perfusate. In this example at a norepi- 
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Table I. Hemodynamic response to norepinephrine 
Distal pressure (ram Hg) 
State Initial Final 
Flow rate (ml/min) Resistance (mm Hg/rnl/min) 
Initial Final Initial Final EDso (-logM) 
Hemodynamically NOR 79.8 ± 1.1 
nonresponsive MAX 66.7 ± 1.3" 
ITAs (n = 9) 
Responsive ITAs NOR 78.0 ± 0.6 
(n = 5) MAX 63.2 ± 2.2* 
GEAs (n = 8) NOR 77.5 ± 0.5 
MAX 49.5 ± 3.8"~ 
79.2 ± 1.2 17.2 ± 1.6 16.4 ± 1.1 0.001 -+ 0.07 0.03 -+ 0.09 NA 
66.4 ± 1.3" 104.0 ± 2.5* 102.0 ± 2.5* 0.10 ± 0.00" 0.10 ± 0.00" NA 
77.6 ± 0.53 15.6 ± 1.9 15.3 -+ 1.7 0.15 -+ 0.06 0.18 ± 0.05 NA 
27.0 ± 1.9? 99.4 ± 5.0* 45.4 ± 2.7t 0.17 ± 0.02 1.18 ± 0.06? 8.04 ± 0.58 
35.0 ± 2.6t 14.1 ± 0.6 4.8 ± 0.8? 0.13 ± 0.05 14.9 -+ 5.7t 5.90 -+ 0.00 
8.6 ± 1.4"t$ 80.0 ± 3.7"~ 6.8 ± 1.6t~ 0.39 ± 0.06t 25.9 ± l l .0t~ 7.49 ± 0.36* 
All data given as mean plus or minus the standard error. Final, Response obtained at 10 .5 mol/L norepinephrine; NOR, normal flow demands; NA, not 
applicable; MAJL, supramaximal flow demands. 
*p < 0.05 compared with normal value. 
tp < 0.05 compared with initial value. 
Sp < 0.05 compared with responsive ITAs. 
nephrine concentration of only 10 _9 mol/L, distal 
pressure and flow started to decrease. Distal pres- 
sure and flow continued to decrease with further 
doses of norepinephrine (EDso = 3.3 x 10-8). The 
final value for flow was similar to that in Fig. 2, A, 
despite the presence of a lower distal resistance. 
At normal flow demands, the ITAs were hemo- 
dynamically nonresponsive to norepinephrine; that 
is, distal pressure and flow were unaltered even at 
the highest norepinephrine concentration. On the 
basis of the hemodynamic response to norepineph- 
fine at supramaximal flow demands, the ITAs were 
divided into two groups: hemodynamically nonre- 
sponsive (N = 9) and responsive (N = 5). Fig. 3, A, 
presents the typical pressure and flow versus time 
from a hemodynamically nonresponsive ITA. Supra- 
maximal flow demands resulted in an initial drop in 
distal pressure and an initial flow rate of 102 ml/min. 
Norepinephrine was added incrementally to the 
perfusate, and the artery was visually observed to 
constrict. However, the artery wag still hemodynam- 
ically nonresponsive to norepinephrine: distal pres- 
sure and flow were unaltered even at the highest 
norepinephrine concentration (10 -5 mol/L). 
Fig. 3, B, presents the typical pressure and flow 
data for a responsive ITA. At supramaximal flow 
demands (Fig. 3, B), the artery had an initial drop in 
distal pressure of 19 mm Hg and a flow rate of 113 
ml/min. With supramaximal flow demands (Fig. 3, 
B), the artery was responsive to norepinephrine. 
Distal pressure and flow started to decrease at a 
norepinephrine concentration of 10 -9 mol/L. 
Higher concentrations of norepinephrine caused a 
dose-dependent decrease in distal pressure and flow 
rate resulting in a final distal pressure and flow rate 
of 23 mm Hg and 51 ml/min, respectively. 
Table I summarizes the results. The hemodynami- 
cally nonresponsive ITAs had no hemodynamic re- 
sponses to norepinephrine at both normal and supra- 
maximal flow demands. At normal flow demands, 
norepinephrine had no effect on distal pressure, flow 
rate, or arterial resistance: the initial and final values 
were almost identical. Supramaximal flow demands 
caused an initial drop in the distal pressure, but even at 
the highest norepinephrine concentration distal pres- 
sure, flow, and arterial resistance were unaltered. For 
the hemodynamically responsive ITA, distal pressure, 
flow rate, and arterial resistances were unaltered by 
norepinephrine under normal flow conditions. Supra- 
maximal flow demands (low distal resistance) de- 
creased the initial distal pressure and increased the 
sensitivity to norepinephrine. In response to norepi- 
nephrine, distal pressure and flow decreased and arte- 
rial resistance increased significantly. In the GEA, 
norepinephrine caused a dose-dependent decrease in 
distal pressure and flow and an increase in arterial 
resistance under normal flow conditions. Lowering the 
distal resistance increased by more than 39-fold the 
sensitivity to norepinephrine for the GEA (EDso from 
5.90 __ 0.09 [1.26 x 10 -6 mol/L] to 7.49 _+ 0.36 -logM 
[3.23 × 10 -8 mol/L]). 
For the hemodynamically responsive ITAs and 
GEAs, Fig. 4, A and B, highlights this increased 
sensitivity to norepinephrine evidenced by decreas- 
ing the distal resistance and thereby decreasing 
distal pressure. For each norepinephrine dose-re- 
sponse relation, the flow values were expressed as a 
percentage of the initial flow. In these normalized 
flow versus norepinephrine plots, decreasing the 
distal resistance increased the sensitivity to norepi- 
nephrine at every norepinephrine dose for both the 
small ITAs (Fig. 4, A) and GEAs (Fig. 4, B). 
Dimensional analysis. Table II summarizes the 
dimensional nalysis. As previously stated, the ITAs 
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were divided into two groups on the basis of the 
hemodynamic response to norepinephrine. The he- 
modynamically nonresponsive ITAs had a slight i00 
taper with a 22.8% difference between the proximal 
and distal diameter. The responsive ITAs had a 80 
proximal diameter size similar to that of the hemo- 
dynamically nonresponsive ITAs. However, the dis- ~ e0 
o 
tal diameter was significantly smaller. Further, there 
c 
wasnoover lap intherangeinthed is ta ld iameter  ~ i t  
data: the largest distal diameter (1.5 mm) in the £. 
responsive ITA group was smaller than the smallest 
distal diameter (2.05 mm) in the hemodynamically 
nonresponsive group. The hemodynamically respon- 
sive ITAs were also more tapered with a difference A e 
of 64% difference between the proximal and distal 
ends. The GEAs were significantly smaller than the 
hemodynamically nonresponsive ITAs at every loca- 
tion. The GEAs were also smaller than the proximal 
and middle diameters of the responsive ITAs, but lOO 
there were no significant differences between the 
distal diameters. These porcine GEAs were rela- e0 
tively nontapered with only an 11% difference be- ~ 8o 
tween the proximal and distal ends. " 
Prox imal  versus  d is ta l  responses .  In four respon- 
sive ITA and eight GEA experiments, after the ~. ~ 
norepinephrine r sponse at supramaximal flow was 
recorded, the artery was divided in half and each 
half was reattached to the perfusion system. The 
norepinephrine r sponse was then determined for 0 
the proximal and distal halves. Fig. 5, A and B, B 
compares norepinephrine responses inproximal and 
distal halves from one ITA experiment. Both seg- 
ments were perfused at 80 mm Hg at supramaximal 
flow demands (low distal resistance). Initial and 
final values for distal pressure and flow rate did not 
change in the proximal half even at the highest 
norepinephrine concentration. However, the distal 
half presented similar responses to those of the 
entire artery with a 57.5% decrease in distal pres- 
sure and a 52.6% decrease in flow rate at the final 
concentration f norepinephrine. 
Table III summarizes the comparison of proximal 
and distal arterial segments. For the tapered ITA, 
the proximal segment was significantly larger than 
the distal segment. The response to norepinephrine 
was also very different. In the proximal segment, 
final values for distal pressure, flow rate, and arterial 
resistance were unaltered even at the highest con- 
centration of norepinephrine. However, for the dis- 
tal segment, distal pressure and flow rate decreased. 
For the GEA, the responses to norepinephrine w re 
similar in the proximal and distal segments. In both 
Percent of Normalized Flow in the Responsive ITA 
Normal Flow 
--II-- Supramaxtrnal Flow 
19 I I I I I .61 I I 
- .8 -7 -5 
Norepinephrine (M) 
Percent of Normalized Flow in the GEA 
--II- Supramaxlmal Flow ~ ~ 
19 1 I I I I I I I 
- -8 -7 -6 -5 
Norepinephrine (M) 
Fig. 4. A and B, Increased sensitivity o norepinephrine 
at supramaximal flow demands i highlighted. For each 
norepinephrine dose-response relation, flow values were 
expressed aspercentage ofcontrol flow. In these normal- 
ized plots of flow versus norepinephrine, d creasing distal 
resistance increased sensitivity onorepinephrine at every 
norepinephrine dose for both small ITAs (A) and GEAs 
(B) (*p < 0.05 compared with normal flow demand value). 
segments, norepinephrine caused a dose-dependent 
decrease in distal pressure and flow rate and an 
increase in arterial resistance. 
Discuss ion  
We examined potential mechanisms for insuffi- 
cient graft flow and susceptibility ovasoconstriction 
in ITA and GEA arteries. Porcine GEAs and small 
and large ITAs were examined in an in vitro perfu- 
sion system. The key findings were (1) with normal 
flow demands, norepinephrine-induced vasocon- 
striction caused a slight decrease in flow rate in the 
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Table II. Dimensional nalysis of ITA and GEA 
Proximal 
Vessel diameter (mm) 
Middle Distal 
Hemodynamically 
nonresponsive 
ITA (range) 
Responsive ITA 
(range) 
GEA (range) 
3.00 -+ 0.08 (2.8-3.3) 
3.21 -+ 0.13 (2.95-3.55) 
1.65 -+ 0.09 (1.26-1.95)~: 
2.76 -+ 0.06 (2.45-3.0) 
2.39 -+ 0.26 (2.1-2.9)* 
1.68 -+ 0.14 (1.0-1.98):~ 
2.31 -+ 0.10 (2.05-2.55)*t 
1.16 - 0.18 (0.75-1.5)*t~ 
1.47 -+ 0.09 (0.98-1.71):~ 
All data given as mean plus or minus the standard error. 
*p < 0.05 compared with proximal diameter. 
tp < 0.05 compared with middle diameter. 
:~p < 0.05 compared with hemodynamically nonresponsive ITA. 
GEA, and this flow rate decrease only occurred at 
high norepinephrine concentrations, (2) increasing 
flow demands increased the sensitivity to norepi- 
nephrine and led to large decreases in flow rate in 
both the small ITA and GEA, (3) norepinephrine- 
induced decreases in flow rate did not occur in the 
larger ITAs, (4) in the relatively nontapered GEA, 
both the proximal and distal segment were vulnera- 
ble to norepinephrine-induced flow decreases, and 
(5) in the tapered ITA, the proximal segments were 
less sensitive to norepinephrine. 
Mechanism. The diameter of a vessel is deter- 
mined by the balance between distending pressure 
and vasomotor forces. We believe that the interac- 
tion of intraluminal pressure changes and vasocon- 
striction can explain the results of this study. Al- 
though often overlooked, intraluminal arterial 
pressure is a major determinant of vessel size and is 
the afterload against which vasoconstrictors work. 2° 
The pressure-induced vessel dimension changes 
equal in magnitude the vasoconstriction-induced 
dimensional changes. Germane to the present study, 
the effects of vasoactive agents are directly related 
to intraluminal pressure; that is, high arterial pres- 
sures (afterload) inhibit vasoconstriction. In one 
study that used a uniform vasoconstriction stimu- 
lus, 2° the arterial diameter decreased by 30% at an 
intraluminal pressure of 20 mm Hg, whereas no 
effective vessel shortening occurred at an intralumi- 
nal pressure higher than 140 mm Hg. 
In normal large-conduit arteries, localized vaso- 
constriction does not alter intraluminal pressure. 
Thus arterial pressure is ignored when vasoreactivity 
is considered. However, in stenotic arteries by the 
conversion of potential to kinetic energy and in long 
bypass arterial grafts by accumulative iscous energy 
losses, intraluminal pressure can change substan- 
tially. In previous studies on stenotic arteries, we 
observed a close relationship between intraluminal 
pressure changes, flow rate, and dimensions) < 18 
Exaggerated shortening occurred when the stenotic 
arterial distending pressure decreased. In another 
study, changing stenotic pressure altered the hemo- 
dynamic response to norepinephrineY Interven- 
tions that raised stenotic pressure increased the 
threshold concentration of norepinephrine r quired 
to reduce flow, whereas interventions that lowered 
stenotic pressure decreased the threshold concen- 
tration of norepinephrine. These pressure-induced 
alterations in the hemodynamic responses did not 
occur in normal arteries. 21 
We believe that this same interaction of reduced 
distal intraluminal pressure and vasoconstriction 
can explain how a normal artery becomes uscepti- 
ble to spasm when used as an artery graft (Fig. 6). 
With normal flow demands, only a small pressure 
drop occurs along the artery. However, after bypass, 
a small-diameter artery experiences much higher 
flow rates than normal. These supramaximal flow 
rates cause large pressure drops along the vessel 
(see Figs. 2 and 3 and Table I). Under these 
conditions, vasoconstrictors can further decrease 
the luminal area, leading to further decreases in 
intraluminal pressure; that is, there is a positive 
feedback mechanism. Thus, in an arterial graft, as 
the artery begins to constrict he intraluminal pres- 
sure opposing constriction (afterload) decreases 
dramatically. The combination of constriction and 
pressure decreases results in exaggerated diameter 
reductions and can cause vasospasm with a para- 
doxic decrease in flow. 
The GEAs were hemodynamically more respon- 
sive to norepinephrine than the ITAs: the flow 
decrease and the arterial resistance increase were 
greater in the GEA than respective findings in the 
responsive ITA. The data suggest that this increased 
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Fig. 5. ITAs were tapered and responses were different in proximal (A) and distal (B) halves. Initial and 
final values for distal pressure and flow were higher in proximal half. Likewise, sensitivity to norepinephrine 
(NE) was different. 
Table III. Proximal versus distal arterial segment responses to norepinephrine 
Distal pressure (mm Hg) Flow rate (ml/min) Resistance (mm Hg/ml/min) 
ED5o 
Half Initial Final Initial Final Initial Final ( - logM) 
I TA  Proximal  58.5 ± 1.2 57.5 --- 1.3 114.0 --- 1.4 113.0 ___ 1.7 0.19 ___ 0.01 0.19 _+ 0.01 NA 
Distal  58.8 --- 0.6 25.0 --- 4.8* 113.0 ± 1.7 53.5 ± 9.4* 0.20 ___ 0.01 0.18 _+ 0.29* 7.36 • 0.40 
GEA Proximal  58.0 ± 2.3 10.0 ± 1.4t 93.8 ± 3.3 11.6 ± 2.4? 0.23 ± 0.03 8.7 ± 2.5? 6.96 ± 0.33 
Distal  53.2 ± 4.8 7.3 --- 1.77 82.2 --+ 4.2 9.3 ± 2.7? 0.34 _+ 0.08 11.1 ± 2.9? 7.50 _ 0.51 
All data given as mean plus or minus the standard error. NA, Not applicable. 
*p < 0.05 compared with proximal value. 
"i'p < 0.05 compared with initial value. 
responsiveness may be a result, in part, of arterial 
size. The proximal and middle diameters of the 
GEA were smaller than the ITA diameters. As 
might be expected from basic hemodynamics, arte- 
rial length was also an important factor. This com- 
bination of long length and narrow diameter may 
account for the accentuated hemodynamic re- 
sponses observed in the GEA. 
9 6 0 Spence, Montgomery, Santamore 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
2, 
t.5, 
E g 
E ._m 
Constriction Within an Arterial Graft Dilated 
ricted 
/ /~ '~ Constriction with Normal Flow 
¢ D ~  ~ Demands 
Constriction Under Supramaximal Flow 
Demands 0.5 
0 I I I I I I ! I I 
0 20 40 60 80 t00 t20 140 160 1so 
Intraluminal Pressure (mmHg) 
Fig. 6. Schematic representation f proposed mechanism for spasm. Maximally dilated and maximally 
constricted artery diameter versus intraluminal pressure relationship are shown. Under normal flow 
conditions, vasoconstrictor results in shift from A to B with no change in intraluminal pressure and 
relatively small change in vessel diameter. High flow conditions decrease intraluminal pressure with slight 
decrease in diameter, point A to C. Vasoconstriction now results in substantial drop in intraluminal 
pressure; synergistic actions of vasoconstriction and intraluminal pressure decrease result in exaggerated 
decrease in diameter, point C to D. 
Implications. These supramaximal flow demands 
increase the sensitivity of the arterial grafts to 
norepinephrine, with resulting effective EDso values 
within the range of perioperative circulating norepi- 
nephrine levels. In normal persons, mean circulating 
norepinephrine l vels are about 1.67 × 10 -9 mol/L 
and increase to 5.6 × 10 -9 mol/L with activity. 22 
Anesthesia nd coronary artery bypass grafting raise 
norepinephrine l vels from 200 to 700 pg/ml (1.2 × 
10 -9 to 4.1 x 10 -9 mol/L) and these levels remain 
elevated for up to 24 hours after operation. 23 In 
instances of deep hypothermia with circulatory ar- 
rest, the norepinephrine l vels are even higher with 
a mean peak concentration of 4543 pg/ml (2.7 x 
10 -8 mol/L) reached uring rewarming. Thus, with 
supramaximal f ow demands, the effective EDs0 
values are within the range of circulating norepi- 
nephrine levels that occur during the perioperative 
period and can render the arterial grafts susceptible 
to spasm. 
The results of the present study also provide a 
theoretic basis for many practical procedures used 
by surgeons to prevent insufficiency. This study 
indicates that the long length and small diameter of 
an arterial graft can restrict flow through the vessel 
and might cause insufficiency. In many patients 
postoperative myocardial perfusion may not be ex- 
clusively dependent on ITA graft flow for many 
reasons, such as good collateral circulation and the 
absence of critical coronary stenosis. In such cases 
early ITA vasospasm is unlikely to be a clinical 
problem. However, spasm may be a severe problem 
in situations that demand supramaximal flow rates. 
The higher flow rates can decrease pressure within 
the arterial graft, leaving the graft vulnerable to 
vasoconstriction a d spasm and leading to a para- 
doxic decrease in flow rate. This situation can be 
anticipated with ventricular hypertrophy, when a 
vein graft is replaced at reoperation, or possibly 
when multiple arterial grafts are used. 
On a practical basis there are several approaches 
for the surgeon to prevent graft insufficiency. Prep- 
aration of the arterial conduit is most important. 
The conduit should be handled carefully and con- 
sideration should be given to dilation by mechanical 
and pharmacologic means. This should decrease the 
sensitivity to endogenous and exogenous vasocon- 
strictors. The conduit can be cut to the shortest 
length possible, removing the tapered part of the 
vessel, and thus eliminating a segment of vessel that 
may be more prone to spasm. 24 This study particu- 
larly demonstrates how the distal ITA segment 
The Journal of Thoracic and 
CardiovascuLar Surgery 
Volume 110, Number 4, Part 1 
Spence, Montgomery, Santamore 9 6 1 
(tapered) is responsible for the spasm observed. 
However, this option will not be available for non- 
tapered arterial grafts. In our study, the proximal 
and distal segments of the relatively nontapered 
porcine GEA had similar responses. 
When high flow demands are anticipated, supple- 
mentary grafting with a saphenous vein may be 
advisable. The vein can be applied to the same 
coronary vessel or to one that is adjacent o the 
coronary vessel (such as a diagonal). The vein graft 
provides additional flow to support he myocardium 
and reduces the flow rate in the arterial graft. The 
reduced flow rate should reduce the pressure loss 
along the arterial graft and decrease the risk of 
spasm in the arterial graft. Clearly this strategy 
places the arterial graft in direct competition with 
the vein. Many fear the development of the string 
sign under these circumstances. However, the im- 
mediate survival of the patient is often at stake and 
so this is only a secondary consideration. It is 
interesting, however, that recent clinical experience 
suggests that ITA narrowing may be a reversible 
phenomenon and that when high flow demand 
occurs the arterial grafts may revert to a more 
normal size. 2528 
We would like to express our thanks to Fischer's 
Packing Company of Louisville, Kentucky, for their sup- 
port in the conduct of this experiment. 
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